Literature DB >> 19452598

The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin.

Jonathan Langdown1, Klara J Belzar, Wendy J Savory, Trevor P Baglin, James A Huntington.   

Abstract

Antithrombin (AT) is the most important inhibitor of coagulation proteases. Its activity is stimulated by glycosaminoglycans, such as heparin, through allosteric and template mechanisms. AT utilises an induced-fit mechanism to bind with high affinity to a pentasaccharide sequence found in about one-third of heparin chains. The conformational changes behind this mechanism have been characterised by several crystal structures of AT in the absence and in the presence of pentasaccharide. Pentasaccharide binding ultimately results in a conformational change that improves affinity by about 1000-fold. Crystal structures show several differences, including the expulsion of the hinge region of the reactive centre loop from beta-sheet A, which is known to be critical for the allosteric activation of AT. Here, we present data that reveal an energetically distinct intermediate on the path to full activation where the majority of conformational changes have already occurred. A crystal structure of this intermediate shows that the hinge region is in a native-like state in spite of having the pentasaccharide bound in the normal fashion. We engineered a disulfide bond to lock the hinge in its native position to determine the energetic contributions of the initial and final conformational events. Approximately 60% of the free-energy contribution of conformational change is provided by the final step of hinge-region expulsion and subsequent closure of the main beta-sheet A. A new analysis of the individual structural changes provides a plausible mechanism for propagation of conformational change from the heparin binding site to the remote hinge region in beta-sheet A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19452598      PMCID: PMC2697666          DOI: 10.1016/j.jmb.2009.01.028

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

1.  Structure of a serpin-protease complex shows inhibition by deformation.

Authors:  J A Huntington; R J Read; R W Carrell
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

2.  A mechanism for heparin-induced potentiation of antithrombin III.

Authors:  C A van Boeckel; P D Grootenhuis; A Visser
Journal:  Nat Struct Biol       Date:  1994-07

3.  A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor.

Authors:  L T Hunt; M O Dayhoff
Journal:  Biochem Biophys Res Commun       Date:  1980-07-31       Impact factor: 3.575

4.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

5.  Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.

Authors:  Daniel J D Johnson; Wei Li; Ty E Adams; James A Huntington
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

6.  Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding.

Authors:  J L Meagher; J M Beechem; S T Olson; P G Gettins
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

7.  Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.

Authors:  S T Olson
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

8.  Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction.

Authors:  S T Olson; K R Srinivasan; I Björk; J D Shore
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

9.  Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.

Authors:  Wei Li; Daniel J D Johnson; Charles T Esmon; James A Huntington
Journal:  Nat Struct Mol Biol       Date:  2004-08-15       Impact factor: 15.369

10.  Crystal structure of antithrombin in a heparin-bound intermediate state.

Authors:  Daniel J D Johnson; James A Huntington
Journal:  Biochemistry       Date:  2003-07-29       Impact factor: 3.162

View more
  19 in total

1.  Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.

Authors:  Irene Martínez-Martínez; Adriana Ordóñez; José Navarro-Fernández; Angel Pérez-Lara; Ricardo Gutiérrez-Gallego; Rafael Giraldo; Constantino Martínez; Esther Llop; Vicente Vicente; Javier Corral
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

2.  Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate.

Authors:  Zhangjie Wang; Po-Hung Hsieh; Yongmei Xu; David Thieker; Evangeline Juan En Chai; Shaoshuai Xie; Brian Cooley; Robert J Woods; Lianli Chi; Jian Liu
Journal:  J Am Chem Soc       Date:  2017-04-03       Impact factor: 15.419

Review 3.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

Review 4.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

5.  Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes.

Authors:  Sophia Schedin-Weiss; Benjamin Richard; Steven T Olson
Journal:  Arch Biochem Biophys       Date:  2010-09-15       Impact factor: 4.013

6.  Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.

Authors:  Gonzalo Izaguirre; Sonia Aguila; Lixin Qi; Richard Swanson; Ryan Roth; Alireza R Rezaie; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

7.  Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States.

Authors:  Ryan Roth; Richard Swanson; Gonzalo Izaguirre; Susan C Bock; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

8.  Investigating changes in the gas-phase conformation of Antithrombin III upon binding of Arixtra using traveling wave ion mobility spectrometry (TWIMS).

Authors:  Yuejie Zhao; Arunima Singh; Lingyun Li; Robert J Linhardt; Yongmei Xu; Jian Liu; Robert J Woods; I Jonathan Amster
Journal:  Analyst       Date:  2015-10-21       Impact factor: 4.616

9.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism.

Authors:  Brendan P McDonnell; Kate Glennon; Aoife McTiernan; Hugh D O'Connor; Colin Kirkham; Barry Kevane; Jennifer C Donnelly; Fionnuala Ni Áinle
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.